Product Information
CEFPODOXIME 100 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.0434 per EA under NDC 65862009501. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 11, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the CEFPODOXIME PROXETIL market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862009501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFPODOXIME PROXETILApproval Type
Generic (ANDA)
FDA Application
ANDA065370FDA Approved
6/11/2007
TE Code
AB
On Market Since
6/11/2007
Pharmacological Classes
Price Statistics
The NADAC for CEFPODOXIME 100 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0434 per EA |
|---|---|
| All-time high | $5.5791 (Jun 10, 2015) |
| All-time low | $0.8312 (Nov 20, 2024) |
| 52-week high | $1.2166 |
| 52-week low | $1.0434 |
| Median price | $3.2811 |
| Average price | $3.1280 |
| Largest weekly change | +46.8% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CEFPODOXIME PROXETIL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFPODOXIME 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPODOXIME 100 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.0434 per EA (NDC 65862009501), effective Sep 30, 2026.
How has the price of CEFPODOXIME 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPODOXIME 100 MG TABLET has declined 78.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPODOXIME 100 MG TABLET?
Since Nov 28, 2013, the NADAC for CEFPODOXIME 100 MG TABLET has ranged from a low of $0.8312 (Nov 20, 2024) to a high of $5.5791 (Jun 10, 2015), with a median of $3.2811 per EA.
Are there cheaper alternatives to CEFPODOXIME 100 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFPODOXIME 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFPODOXIME 100 MG TABLET?
CEFPODOXIME 100 MG TABLET (NDC 65862009501) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.